Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MCKESSON CORPORATION

(MCK)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/20/2021 10/21/2021 10/22/2021 10/25/2021 10/26/2021 Date
206.09(c) 207.19(c) 209.09(c) 207.45(c) 207.97(c) Last
493 508 383 560 339 718 628 967 777 808 Volume
+1.73% +0.53% +0.92% -0.78% +0.25% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 253 B - -
Net income 2022 2 424 M - -
Net Debt 2022 358 M - -
P/E ratio 2022 13,4x
Yield 2022 0,88%
Sales 2023 259 B - -
Net income 2023 2 608 M - -
Net cash position 2023 1 131 M - -
P/E ratio 2023 12,0x
Yield 2023 0,92%
Capitalization 32 168 M 32 168 M -
EV / Sales 2022 0,13x
EV / Sales 2023 0,12x
Nbr of Employees 67 500
Free-Float 56,4%
More Financials
Company
McKesson Corporation is focused distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The CompanyÔÇÖs segments include U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment provides distribution and logistics services for branded, generic, specialty, biosimilar, and... 
Sector
Drug Retailers
Calendar
11/01Earnings Release
More about the company
Ratings of McKesson Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about MCKESSON CORPORATION
10/20MCKESSON : Health Mart Unveils Digital Portfolio for Community Pharmacies
PU
10/06MCKESSON CORP : Change in Directors or Principal Officers (form 8-K)
AQ
10/06McKesson Corporation Announces the Resignation of Kenneth E. Washington from its Board ..
CI
10/04WALGREENS BOOTS ALLIANCE : Pharmacy chains failed to prevent opioid misuse, U.S. jury hear..
RE
10/04U.S. Supreme Court rejects challenge to New York tax on opioid companies
RE
10/01Pharmacy chains face first trial in U.S. opioid litigation, judge urges settlement
RE
09/30ENDO INTERNATIONAL : California judge questions counties' opioid case against drugmakers a..
RE
09/30ENDO INTERNATIONAL : California judge questions counties' opioid case against drugmakers a..
RE
09/29CAH and MCK - Distributors Announce Settlement with Cherokee Nation
AQ
09/28Three US Opioid Distributors Settle Opioid-Related Claims With Cherokee Nation
MT
09/28Drug distributors strike 1st opioid settlement with Native American tribe for $75 mln
RE
09/27MCKESSON CORPORATION : to Announce Second Quarter Fiscal 2022 Results on November 1, 2021
BU
09/16MCKESSON CORP : Change in Directors or Principal Officers (form 8-K)
AQ
09/16McKesson Corporation Appoints Kevin W. Emerson as Senior Vice President, Controller and..
CI
09/16McKesson Corporation Launches Rapid Returns Solution for Health Systems
CI
More news
News in other languages on MCKESSON CORPORATION
09/28Trois distributeurs américains d'opioïdes règlent des réclamations liées aux opioïdes a..
09/15VENTE D'INITIÉS : Mckesson
09/06┐Qué hacemos ahora?
09/06Qu'est-ce qu'on fait maintenant ?
09/06EN DIRECT DES MARCHES : TotalEnergies, Airbus, EDF, Spie, Holcim, J&J, Revolut...
More news
Analyst Recommendations on MCKESSON CORPORATION
More recommendations
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MCK | US58155Q1031 | MarketScreener
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Last Close Price 207,97 $
Average target price 239,23 $
Spread / Average Target 15,0%
EPS Revisions
Managers and Directors
Brian Scott Tyler Chief Executive Officer & Director
Britt J. Vitalone Chief Financial Officer & Executive Vice President
Edward A. Mueller Independent Chairman
Nancy Flores Chief Technology & Information Officer, EVP
Donald R. Knauss Independent Director
Sector and Competitors